1. Fassnacht M, Libé R, Kroiss M, Allolio B: Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol. 2011, 7 (6): 323-335. 10.1038/nrendo.2010.235.
2. Beuschlein F, Obracay J, Saeger W, Kroiss M, Quinkler M, Lichtenauer UD, Deutschbein T, Ronchi CL, Willenberg H, Reisch N, Reincke M, Libe R, Baudin E, Bertherat JY, Haak H, Feelders RA, de Krijger R, Loli P, Terzolo M, Allolio B, Mueller H-H, Fassnacht M: Prognostic value of histological markers in localized adrenocortical carcinoma after complete resection. Endocr Rev. 2013, 34: OR29-23.
3. Libé R, Borget I, Ronchi CL, Terzolo M, Haaf M, Laino F, Kerkhofs T, Corsini E, Tabarin A, Chabre O, de la Fouchardière C, Niccoli P, Caron P, Mannelli M, Haak H, Beuschlein F, Bertherat J, Berruti A, Fassnacht M, Baudin E: Prognostic factors of advanced unresectable by stage III and IV ENS@T adrenocortical carcinomas (ACC). Endocr Abstr. 2013, 32: OC4.3-
4. Fassnacht M, Kroiss M, Allolio B: Update in adrenocortical carcinoma. J Clin Endocrinol Metab. 2013, 98 (12): 4551-4564. 10.1210/jc.2013-3020.
5. Dowsett M, Nielsen TO, A’Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF: Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in breast cancer working group. J Natl Cancer Inst. 2011, 103 (22): 1656-1664. 10.1093/jnci/djr393.